Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More
Xconomy
MAY 10, 2019
The market for drugs for rare or “orphan” diseases continues to grow. An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales. Soon there could be three.
97 
Let's personalize your content